Skip to content

Secondary PRevention in Cardiovascular Disease by a Nursing Guided Program (SPRING)

A Remote Nursing-Guided Secondary Prevention Programme in Acute Coronary Syndrome. The SPRING Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03234023
Acronym
SPRING
Enrollment
484
Registered
2017-07-31
Start date
2017-10-01
Completion date
2023-02-05
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Nutrition, Physical Activity, Secondary Prevention

Brief summary

DESIGN: Controlled clinical trial with single randomization, unmasked, open and multicentric. CENTERS: University Hospital of A Coruña and University Hospital of Ferrol CONDITION TO STUDY: Acute Coronary Syndrome (ACS). INTERVENTION:monitored outhospital not inhospital supervised. MAIN OBJECTIVE: To determine the incidence of major adverse events (total mortality, new ACS, coronary revascularization, all-cause hospitalization) during the one-year period after hospitalization for ACS.

Detailed description

The SPRING study aims to learn whether a remote, nurse-guided secondary prevention program reduces adverse events in patients who suffer an infarction during the subsequent one-year period. The SPRING study focuses not only on adverse events but also on the patients' state of life in terms of diet, physical exercise, emotional state, tobacco use, and adherence to medical treatment. Nursing is a profession in charge of preserving the health of patients, which is why the remote secondary cardiovascular prevention program of this study is coordinated by a nurse.

Interventions

BEHAVIORALINTERVENTION GROUP

Offer recommendations of healthy living habits and control of pharmacy administration

Sponsors

University Hospital A Coruña
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* All patients who have suffered an ACS in the health area of A Coruña or Ferrol from the beginning of the study inclusion period until reaching the fixed sample size. * Ages between 18 and 75 years. * Patients with ability to read and understand the participation sheet in the study. * Patients signing informed consent to participate in the study. * Patients living in the health care area of HUAC or HUF.

Exclusion criteria

* Patients who are dependent for the Basic Activities of Daily Living (BADL) or who suffer from severe cognitive impairment (which makes reliable anamnesis impossible). * Patients with a Left Ventricular Ejection Fraction (LVEF) less than or equal to 35%. * Patients with a NYHA III / IV score and / or the Canadian Cardiovascular Association (CCS) scale of IV.

Design outcomes

Primary

MeasureTime frameDescription
major adverse events1 yeartotal mortality, new ACS, coronary revascularization, hospitalization for any cause

Secondary

MeasureTime frameDescription
cardiovascular hospitalizationone yearcardiovascular hospitalization
stroke1 yearstroke
tobacco1 yearquestionnaire
cardiovascular mortality1 yearcardiovascular mortality
nutrition1 yearmediterranean diet
emotion state1 yearquestionnaire
physical activity1 yearmets

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026